Wellbutrin XL: Uses, Dosage & Safety Information

Wellbutrin XL

Wellbutrin XL

Wellbutrin XL

Bupropion hydrochloride
Once-a-day morning brand of a dopamine- and noradrenaline-acting antidepressant, also started each autumn to stop winter depression from returning in adults. Seizures that rise with dose are its chief hazard, and it may push up arterial pressure in some people.
  • ActiveIngredient: Bupropion hydrochloride
  • DosageForm: Extended-release tablet
  • Dosage: 150 mg, 300 mg
  • Indications: Major depressive disorder; prevention of seasonal affective disorder
  • Manufacturer: Bausch Health
  • Storage: 25°C (77°F); excursions 15–30°C
  • Drug Status: Prescription Only

What is Wellbutrin XL?

Wellbutrin XL is Bausch Health’s extended-release bupropion, approved in August 2003 for major depressive disorder and for preventing seasonal affective disorder in adults. Like Wellbutrin SR, it carries a dose-related seizure risk and can raise blood pressure, but it releases bupropion over a full day and is the only Wellbutrin form approved for seasonal depression.1

FDA-approved brand, prescription only
Wellbutrin XL tablets (NDA 021515, approved August 28, 2003) remain prescription products from Bausch Health.2

Approved products and generic therapeutic-equivalence ratings are listed in the FDA Orange Book.3

For seasonal affective disorder, three placebo-controlled trials enrolled adults with a history of autumn-winter depression.1

At the end of treatment, the share of patients who stayed free of a depressive episode was 81.4%, 87.2% and 84.0% with Wellbutrin XL, compared with 69.7%, 78.7% and 69.0% on placebo.1

Seizure incidence has not been formally evaluated for Wellbutrin XL itself; sustained-release bupropion within the usual range carried about a 0.1% incidence.

In those seasonal trials, mean daily doses ranged close to the usual target, and treatment lasted about 4 to 6 months for most patients.1

The tablets are creamy-white to pale yellow and round, printed in black with “Wellbutrin XL” and the strength.

Wellbutrin XL is one of the depression medicines; its depression efficacy rests on trials of the immediate-release formulation.1

How to Take Wellbutrin XL

Morning dose

Take Wellbutrin XL once a day in the morning, with or without food.1

Swallow whole

Swallow the tablet whole; do not crush, divide or chew it.

Missed dose

If you miss a dose, skip it; never take two doses together.

Seasonal plan

For seasonal depression, start in autumn and taper in early spring as your prescriber directs.

Seizures

Seek urgent care for a seizure and do not restart the medicine.

Blood pressure

Have your blood pressure checked before and during treatment.

Mood changes

Report agitation, hostility, depressed mood or thoughts of self-harm straight away.

Sedatives

Do not stop sleeping pills or seizure medicines suddenly while taking it.

MAOIs

Never take it within 14 days of an MAOI.

Rash or swelling

Seek urgent care for rash, hives, swelling or trouble breathing.

Eye pain

Report eye pain, vision changes or eye redness straight away.

Driving

Do not drive until you know how Wellbutrin XL affects your thinking and coordination.

What Are the Side Effects of Wellbutrin XL?

In seasonal affective disorder trials, headache, dry mouth, insomnia and nausea were the most common reactions above placebo.

Wellbutrin XL vs Placebo: SAD
FrequencyEffectNotes
Very common — 34% (placebo 26%)HeadacheSAD trials
Very common — 26% (placebo 15%)Dry mouthSAD trials
Very common — 20% (placebo 13%)InsomniaSAD trials
Very common — 13% (placebo 8%)NauseaSAD trials
Common — 9% (placebo 2%)ConstipationSAD trials
Common — 4% (placebo 1%)Decreased appetiteSAD trials

Source: 1

Seek immediate medical attention if:
  • A seizure, even a brief one
  • Severe headache, confusion or very high blood pressure
  • Agitation, hostility or thoughts of suicide
  • Rash with fever, swelling or trouble breathing
Clinical details

The seasonal affective disorder trials compared 537 people on extended-release bupropion with 511 on placebo.

What is Wellbutrin XL Used For?

Wellbutrin XL is indicated for the treatment of major depressive disorder and for the prevention of seasonal major depressive episodes in adults with seasonal affective disorder.1

Once-daily dosing for depression

Treatment starts once daily in the morning and may be increased after four days to the usual target, taken whole and never crushed, divided or chewed, with or without food.

Seasonal affective disorder

For seasonal depression, treatment begins in autumn before symptoms appear, rises after one week if tolerated, continues through winter and is tapered over about two weeks in early spring.1

Liver and kidney

In moderate to severe hepatic impairment the dose is cut back to dosing every other day, and in kidney impairment a lower dose or frequency is considered.

Seizure precautions

Seizure risk also depends on other conditions such as severe head injury, severe stroke or a CNS tumour. Increases are gradual and the dose is never exceeded, because seizure risk rises with dose; Wellbutrin XL is stopped for good after a seizure.

Children and older adults

Safety and effectiveness in pediatric patients have not been established, and older adults may need a lower dose or less frequent dosing because of reduced kidney function.

Switching

At least 14 days separate Wellbutrin XL from an MAOI antidepressant in either direction.

Interactions Alcohol:

Unsafe
Minimise alcohol, and never stop heavy drinking abruptly while on bupropion because of seizure risk.

Interactions Other Medications:

Use with caution
MAOIs are contraindicated; seizure-threshold and CYP2D6 drugs interact.

Special Groups Pregnancy:

Consult your doctor
Discuss bupropion use in pregnancy with your doctor.

Special Groups Breastfeeding:

Consult your doctor
Discuss breastfeeding during Wellbutrin XL treatment with your doctor.

Special Groups Elderly:

Use with caution
Older adults may need lower doses because of reduced kidney function.

Special Groups Children:

Unsafe
Safety and effectiveness in pediatric patients have not been established.

Effects on Activities Driving:

Use with caution
Bupropion may affect judgment or coordination; check your response before driving.

Effects on Activities Operating Machinery:

Use with caution
Avoid hazardous machinery until you know how Wellbutrin XL affects you.

The seasonal indication is unique to XL

Wellbutrin XL is the only Wellbutrin product approved to prevent seasonal depressive episodes, based on three autumn-to-spring trials.1

Seizure data come from other forms

The labelling states that seizure incidence with Wellbutrin XL has not been formally evaluated, so estimates rely on sustained-release and immediate-release bupropion.

Brand or generic

Generic bupropion extended-release tablets must contain the same active ingredient and be bioequivalent to their reference product.4

Where it comes from

Wellbutrin XL is prescription-only in the US; the FDA’s BeSafeRx guidance lists four signs of a lawful pharmacy website.5

Critical Warnings for Wellbutrin XL Use

Contraindications

Wellbutrin XL is contraindicated with a seizure disorder, current or past bulimia or anorexia nervosa, abrupt withdrawal from alcohol, benzodiazepines, barbiturates or antiepileptics, and MAOI use.1

Seizure

Seizure risk is dose-related and was about 0.1% with sustained-release bupropion in the usual range, so titration is gradual.

Neuropsychiatric events and suicidality

Antidepressants increased suicidality in young people, and serious neuropsychiatric events have been reported with bupropion used for smoking cessation.

Hypertension

Bupropion can raise blood pressure, so it is measured before treatment and periodically.

Other precautions

Mania activation, psychosis, angle-closure glaucoma and allergic reactions are labelled precautions.

See Interactions for the full list of drug combinations.

Dosage

Wellbutrin XL Products
FormulationActive IngredientsClinical Note
TabletsWellbutrin XL150 mg, 300 mg
MDDWellbutrin XLStart 150 mg once daily; 300 mg after 4 days
SADWellbutrin XLStart 150 mg in autumn; 300 mg after 1 week
Kidney: impairmentWellbutrin XLConsider reduced dose or frequency
Liver: moderate to severe impairmentWellbutrin XL150 mg every other day

Source: 1

Exceeding the dose
Overdoses of up to 30 grams or more of bupropion have been reported; seizures occurred in about one-third of cases, and hallucinations, loss of consciousness and mental status changes were among the other serious reactions.1

Marketed strengths and their labelers are listed in the FDA National Drug Code Directory.6

What Does Wellbutrin XL Interact With?

Interactions by Severity
Interacting SubstanceEffect and RiskSeverityDocumentation
MAOIs, linezolid, IV methylene blueHypertensive reactions; contraindicatedMajorGood — labelled
Drugs that lower seizure thresholdHigher seizure riskMajorGood — labelled
CYP2D6 substratesHigher levels of those drugsModerateGood — labelled
CYP2B6 inducers or inhibitorsAltered bupropion levelsModerateGood — labelled

Source: 1

Wellbutrin XL treats major depressive disorder and prevents seasonal affective disorder in adults. It is Bausch Health’s once-daily extended-release bupropion, approved in August 2003. It is not approved for children, and it should not be combined with other bupropion products. Your prescriber sets the dose and timing.
Treatment starts in autumn, before symptoms, at 150 mg of Wellbutrin XL once daily. It rises to 300 mg after a week if tolerated, continues through winter and is tapered in early spring. In three trials, 81.4% to 87.2% of patients stayed free of depression, compared with 69.0% to 78.7% on placebo.
Take Wellbutrin XL once a day in the morning, swallowed whole without crushing, dividing or chewing. For depression it starts at 150 mg and may increase to 300 mg after 4 days. If you miss a dose, skip it; never take two together, because seizure risk rises with dose.
In seasonal depression trials of Wellbutrin XL, headache affected 34% versus 26% on placebo, dry mouth 26% versus 15% and insomnia 20% versus 13%. Nausea, constipation and decreased appetite were also more common. Seizures are uncommon but serious, so report one immediately. Many effects ease over the first weeks.
No. Both contain bupropion, but Wellbutrin XL releases it over a full day and is taken once daily, while Wellbutrin SR, approved in 1996, is taken twice daily. Only Wellbutrin XL is approved for seasonal affective disorder. Switching needs your prescriber’s advice on dose. Never take both together.

Evidence scope

What we know
  • Wellbutrin XL was approved in August 2003.
  • It is approved to prevent seasonal affective disorder.
  • Depression-free rates were 81.4% versus 69.7% in the first seasonal trial.
  • Dry mouth affected 26% versus 15% on placebo in seasonal trials.
What remains uncertain
  • The seizure incidence of Wellbutrin XL itself, which was not formally evaluated.
  • Safety and effectiveness in children.
  • Benefit of seasonal prevention beyond one autumn-to-spring course.

Source: 1

What has been reported to the FDA

Reports to the FDA naming bupropion hydrochloride, including Wellbutrin XL, are summarised on the Wellbutrin SR page.7

Who was this medicine studied in?

Depression efficacy rests on immediate-release bupropion trials, and the seasonal indication on three placebo-controlled prevention trials.1

Who this is and is not appropriate for

Not for people with seizure disorders, eating disorders, abrupt withdrawal from alcohol or sedatives, or MAOI use.

Adults with depression who prefer once-daily dosing, or with a history of autumn-winter depression who start treatment before symptoms.

Where to report and verify

Routing to Official Registries
What you needWhere to go
Report a side effectFDA MedWatch
Pregnancy-specific dataMotherToBaby
Full prescribing informationDailyMed
Verify a pharmacy websiteFDA BeSafeRx · LegitScript

References

  1. FDA Prescribing Information, WELLBUTRIN XL (bupropion hydrochloride) extended-release tablets (Bausch Health; NDA 021515)
    Revised 2026-02 · Accessed 2026-10-26
    Used for: indications incl. SAD, dosing, forms, contraindications, warnings incl. seizure and hypertension, adverse reactions, interactions, specific populations, overdose, clinical studies.
    dailymed.nlm.nih.gov — WELLBUTRIN XL SPL
  2. Drugs@FDA
    Record accessed 2026-10-26
    Used for: application and marketing status.
    accessdata.fda.gov — Drugs@FDA
  3. FDA Orange Book
    Accessed 2026-10-26
    Used for: reference and generic listings.
    accessdata.fda.gov — Orange Book
  4. FDA — Generic Drugs: Questions & Answers
    Accessed 2026-10-26
    Used for: requirements for generic equivalence (same active ingredient, strength, bioequivalence).
    fda.gov — Generic Drugs Q&A
  5. FDA BeSafeRx — signs of a safe pharmacy website (flyer)
    Accessed 2026-10-26
    Used for: four signs of a lawful pharmacy website.
    fda.gov — BeSafeRx
  6. FDA National Drug Code Directory
    Directory accessed 2026-10-26
    Used for: marketed products and strengths.
    accessdata.fda.gov — NDC Directory
  7. FDA Adverse Event Reporting System (openFDA)
    Data cut 2026-07-30 · Accessed 2026-10-26
    Used for: report totals and the ten most frequent terms.
    open.fda.gov — drug adverse event API

How this page was sourced

Clinical and product facts come from the current Wellbutrin XL prescribing information (Bausch Health, February 2026).

Approval data come from Drugs@FDA; the report summary is on the Wellbutrin SR page.

Disclaimer: The information on this site is provided for informational purposes only and is not medical advice. It does not replace professional medical consultation, diagnosis, or treatment. Do not self-medicate based on the information presented on this site. Always consult with a doctor or other qualified healthcare professional before making any decisions about your health.

Medicine graph

FDA-approved uses

  • Major Depressive Disorder

Boxed warning

  • WARNING: SUICIDAL THOUGHTS AND BEHAVIORS

Contraindications (FDA label)

  • Wellbutrin XL is contraindicated in patients with seizure disorder.
  • Wellbutrin XL is contraindicated in patients with a current or prior diagnosis of bulimia or anorexia nervosa as a higher incidence of seizures was observed in such patients treated with Wellbutrin XL.
  • Wellbutrin XL is contraindicated in patients undergoing abrupt discontinuation of alcohol, benzodiazepines, barbiturates, and antiepileptic drugs.

FDA label: NDA021515